Integrated Studies Of Breast, Esophageal, And Gastric Cancers Using High Throughput Technologies And Computational Analyses Maxwell Lee National Cancer.

Slides:



Advertisements
Similar presentations
Most Random Gene Expression Signatures are Significantly Associated with Breast Cancer Outcome Venet, et al. PLoS Computational Biology, 2011 Molly Carroll.
Advertisements

Acquisition of tumour multidrug resistance inevitable in most advanced solid tumours – Failing to cure the majority of advanced solid tumours – Declining.
Vanderbilt Center for Quantitative Sciences Summer Institute Sequencing Analysis Yan Guo.
Genomic DNA Variation Computer-Aided Discovery Methods Baylor College of Medicine course Term 3, 2010/2011 Lecture on Wednesday, February 2 nd,
Comparison of Mutations and Protein Expression in Potentially Actionable Targets in 5500 Triple Negative vs. non-Triple Negative Breast Cancers Joyce A.
Special Topics in Modern Genetics: Epigenetics
Gene regulation in cancer 11/14/07. Overview The hallmark of cancer is uncontrolled cell proliferation. Oncogenes code for proteins that help to regulate.
Bioinformatics lectures at Rice University Li Zhang Lecture 10: Networks and integrative genomic analysis-2 Genome instability and DNA copy number data.
The origin of metastatic disease: clues from genomics 7/13/2011.
By: Katie Adolphsen, Robin Aldrich, Brandon Hu, Nate Havko.
Gene Co-expression Network Analysis BMI 730 Kun Huang Department of Biomedical Informatics Ohio State University.
STAC: A multi-experiment method for analyzing array-based genomic copy number data Sharon J. Diskin, Thomas Eck, Joel P. Greshock, Yael P. Mosse, Tara.
Comparative Genomic Hybridization (CGH). Outline Introduction to gene copy numbers and CGH technology DNA copy number alterations in breast cancer (Pollack.
MDM2: Oncogene Chan Lee. Discovery of MDM2: starting with tumor suppressor p53.
Mitogens stimulate G1-Cdk and G1/S-Cdk activities.
Estrogen and its receptors play an important role in breast carcinogenesis. In humans, there are two subtypes of estrogen receptors (ER), ER  and ER ,
MammaPrint, the story of the 70-gene profile
Metastatic Breast Cancer: One Size Does Not Fit All Clifford Hudis, M.D. Chief, Breast Cancer Medicine Service MSKCC.
Paola CASTAGNOLI Maria FOTI Microarrays. Applicazioni nella genomica funzionale e nel genotyping DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE.
Supplementary Figure 1. Somatic mutation spectrum # Substitutions # Substitutions per Mb b c a Repeats Pseudogenes Whole genome Splice sites Non-coding.
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Radiogenomics in glioblastoma multiforme
The virochip (UCSF) is a spotted microarray. Hybridization of a clinical RNA (cDNA) sample can identify specific viral expression.
Genetics-multistep tumorigenesis genomic integrity & cancer Sections from Weinberg’s ‘the biology of Cancer’ Cancer genetics and genomics Selected.
Investigations into Breast Cancer Etiology: Genomic/Epigenomic Analyses, Novel Oncogenes, and Allele-specific Studies Maxwell Lee National Cancer Institute.
YUEMIN DING Neuro-oncology Group Department of Molecular Neuroscience
Copy Number Variation Eleanor Feingold University of Pittsburgh March 2012.
Other genomic arrays: Methylation, chIP on chip… UBio Training Courses.
Investigations into Etiology of Breast, Esophageal, and Gastric Cancers: Allele-specific Gene Expression and DNA Methylation Signature Maxwell Lee, Ph.D.
Epigenetic Control of Tamoxifen Resistant Breast Cancer Kristin Williams Arcaro Lab Thesis Resarch June 25, 2012 Kristin Williams Arcaro Lab Thesis Resarch.
Signatures of Accelerated Somatic Evolution in Gene Promoters in Multiple Cancer Types Update Talk Kyle Smith De Lab.
Maxwell Lee National Cancer Institute Center for Cancer Research High-dimension Data Analysis Group March 19, 2014 Integrated Studies Of Breast, Esophageal,
Computational Laboratory: aCGH Data Analysis Feb. 4, 2011 Per Chia-Chin Wu.
CBioPortal Web resource for exploring, visualizing, and analyzing multidimentional cancer genomics data.
Cancer Genome Landscapes
Eigengenes as biological signatures Dr. Habil Zare, PhD PI of Oncinfo Lab Assistant Professor, Department of Computer Science Texas State University 5.
Different microarray applications Rita Holdhus Introduction to microarrays September 2010 microarray.no Aim of lecture: To get some basic knowledge about.
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Novel Integrative Methods for Gene Discovery Associated.
Discovery of Novel Methylated Genes in Cervical Carcinogenesis: Methylation of GREM1 and NID2 is Detected in the Majority of Invasive Cervical Cancers.
Cancer Bioinformatics Tom Doman Bioinformatics Scientist Eli Lilly & Company Informatics 519 guest lecture IU Bloomington Sept
Menzies Health Institute Queensland menzies.griffith.edu.au School of Medicine, Griffith University, Gold Coast, Australia Md Hakimul Haque, Vinod Gopalan,
Tumor Heterogeneity: From biological concepts to computational methods Bo Li, PhD Dana Farber Cancer Institute Harvard Statistics Department.
EUKARYOTIC CELL SIGNALING VII Abnormal Signaling in Cancer Signaling to p53 Dr. Ke Shuai Office: 9-240M Factor Tel: X69168
1st workshop of the Aberdeen Microarray Analysis Network (AMAN)
An Overview of The Cancer Genome Atlas (TCGA)
YEATS4 Is a Novel Oncogene Amplified in Non– Small Cell Lung Cancer That Regulates the p53 Pathway Speaker:Dai-Wei Hsuan Adviser:Dr. Guor-Mour, Her Data:2015/04/22.
Molecular Biology of Cancer AND Cancer Informatics (omics) David Boone.
Tumor Genome Sequencing Xiaole Shirley Liu STAT115, STAT215, BIO298, BIST512.
Evolution-informed Modeling discover biomarkers for precision oncology Li Liu, M.D. August 22, 2016.
Samsung Genome Institute Samsung Medical Center
Patient VB Li-Fraumeni Syndrome.
Archival Fine-Needle Aspiration Cytopathology (FNAC) Samples
Figure 2 Copy-number variations in multiple myeloma
Linking Genetic Variation to Important Phenotypes
Volume 2, Issue 4, Pages (April 2008)
Genomic alterations in breast cancer cell line MDA-MB-231.
Intrinsic and acquired trastuzumab resistance.
Volume 29, Issue 5, Pages (May 2016)
Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma
Volume 4, Issue 3, Pages (August 2013)
Volume 29, Issue 5, Pages (May 2016)
Breast Cancer Subtype Identification Using RNA-Seq Data
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours By: Anh Pham.
PD-L1 expression correlates with T-cell markers and an IFN response signature in human melanomas. PD-L1 expression correlates with T-cell markers and an.
CHCHD2 and EGFR protein expression in NSCLC
EN1 expression in breast cancer and clinical outcome.
MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients treated with tamoxifen. MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients.
Tivantinib does not inhibit MET function.
Location of the ER mutations and frequencies per cohort.
Highly metastatic PDAC cells have a unique gene signature, which is not preserved in metastases but predicts poor patient outcome. Highly metastatic PDAC.
Presentation transcript:

Integrated Studies Of Breast, Esophageal, And Gastric Cancers Using High Throughput Technologies And Computational Analyses Maxwell Lee National Cancer Institute Center for Cancer Research High-dimension Data Analysis Group March 19, 2014

Collaborators CCRHoward YangHuaitian Liu Mitsutaka Kadota Lalage WakefieldKent HunterBeverly MockDinah Singer Kevin GardnerJing HuangXin WangLi Yang Thomas RiedStephen HewittPaul MeltzerSean Davis DCEGPhil TaylorNan HuAlisa GoldsteinChristian Abnet Neal FreedmanSandy DawseyGretchen GierachNeil Caporaso Jonine Figueroa CBIITDaoud Meerzaman DCPMark ShermanBarbara DunnRonald LubetAsad Umar DCTDJay JiJason Lih UMASSKathleen Arcaro UNCMelissa Troester Purdue UniversitySulma Mohammed Windber Research InstituteHai Hu Toyama UniversityJunya Fukuoka

Breast cancer 1.Delineating genetic alterations for tumor progression in the MCF10A series of cell lines. 2.Identifying novel oncogenes and functional studies 3.Predicting clinical outcome using DNA methylation and gene expression signatures Esophageal and gastric cancers 1.Microarray data analyses 2.Whole genome sequencing data analyses Outline Of The Talk

1.Delineating genetic alterations for tumor progression in the MCF10A series of cell lines. 2.Identifying novel oncogenes and functional studies 3.Predicting clinical outcome using DNA methylation and gene expression signatures Part 1 Breast Cancer

Modified Wellings-Jensen Model of Breast Cancer Evolution Lee el al. Breast Cancer Res. 2006;8(1):R6.Wellings et al. J Natl Cancer Inst Aug;55(2):

Breast Cancer Progression Models Of The MCF10A Series Of Cell Lines NormalPremalignantLow gradeMetastaticcarcinoma MCF10A M1 MCF10CA1a M4 HRAS G12V MCF10CA1h M3 MCF10AT M2 Santner SJ,..., Miller FR. Breast Cancer Res Treat Jan;65(2): Role of TGF-  Tumor Suppressor Metastasis Promoter Tang B,..., Wakefield LM. J Clin Invest Oct;112(7):

DNA Copy Number Alterations In MCF10A Series Of Cells Detected Using The Affymetrix 500K SNP Arrays Kadota et al PLoS One Feb 15;5(2):e9201. chromosome

MYC Amplification In MCF10A Series Of Cells Detected By DNA Copy Number Analysis Using SNP Arrays Kadota et al PLoS One Feb 15;5(2):e9201. MYC

CDKN2A/CDKN2B Deletions In MCF10A Series Of Cells Detected By DNA Copy Number Analysis Using SNP Arrays CDKN2A/B

PIK3CA Mutation In MCF10CA1h And MCF10CA1a Cells M1M2M3M4 Chr 3 A G A GG G:A = 2:1

DNA Copy Number Alterations In Primary Breast Tumors Detected With SNP Arrays 161 tumors chromosome 161 breast tumors putative novel oncogenes Affymetrix SNP5 array 1q 8q traditional approach my approach size of focal amplification multiple genes 1 gene frequency of tumors with amplification common high frequency not required but must occur in ≥ 1 tumor Kadota et al Cancer Res Sep 15;69(18):

Focal Amplification Detected in Primary Breast Tumors

Focal Amplification Of TBL1XR1 In Breast Tumors Tumor 1 Tumor 2

Frequent Over-expression Of TBL1XR1 In Primary Breast Tumors Using Tissue Microarray (TMA) Well-diffpoorly-diff negative164 positive3515 negative 31% positive 69% N=84 TBL1XR1 expression associates with poorly differentiated tumors with odds ratio = 1.7 In collaboration with Junya Fukuoka at Toyama University

TBL1XR1-shRNA Knockdown in MCF10CA1h (M3) Suppresses In Vivo Tumor Growth tumor volume (mm 3 ) N=10 N=14implants Western Blot In collaboration with Lalage Wakefield 9 of 107 of 101 of 14tumor incidence Day 39 p-value = 0.013

The Polish Breast Cancer Study (PBCS) The PBCS included 2386 cases and 2502 controls They resided in Warsaw, Poland from Median follow-up: 8 years 208 PBCS tumors with Illumina HumanRef-8 v2 Expression data 226 PBCS tumors with Illumina Human Methylation27 data In collaboration with Mark Sherman, Jonine Figueroa, Paul Meltzer, Sean Davis, and Melissa Troester

An Algorithm For Methylation And Expression Index (MEI) Illumina Infinium HumanMethylation27 BeadChip Illumina HumanRef-8 v2 Expression BeadChip Differential methylation based on IHC (positive vs. negative for ER, PR, Her2, EGFR, or CK5) 2227 methylation markers in 1162 genes Top 3% most variable gene expression 541 genes 128 methylation markers in 65 genes MEI: the weighted sum of the gene expression where the weights are the negative numbers of the Spearman correlations.

Polish dataset: K-M survival based on MEI p = Survival Probability Year

Polish dataset: K-M survival using MEI for ER+ and ER- samples Survival Probability p = 0.009p = Survival Probability ER+ cases ER- cases Year

Validation: K-M survival using MEI for ER+ samples TCGA ER+GSE6532 ER+ NKI ER+ METABRIC ER+ Year Year Survival ProbabilityOS OSDMFS p = p = p =

1.Microarray data analyses 2.Whole genome sequencing data analyses Part 2 Esophageal And Gastric Cancers In collaboration with Phil Taylor, Nan Hu, Alisa Goldstein

Clustering Of ESCC And Gastric Cancers Using The Affymetrix U133 Gene Expression Data Wang et al. PLoS One May 22;8(5):e pairs of ESCC 62 pairs of cardia cancer 72 pairs of noncardia cancer t: tumor n: normal

Anatomy Of Esophageal Cancer And Gastric Cancer cardia non-cardia

1,898 ESCC cases 2,100 common control Illumina 660W Quad chip P-value derived from logistic regression models adjusted for age and sex esophageal squamous cell carcinoma (ESCC) Abnet C,..., Taylor P. Nat Genet 2010;42:

1,625gastric cancer 1,110gastric cardia cancer 515gastri non-cardia cancer 2,100common control

Analyses of Whole Genome Sequencing (WGS) Data Generated By The Complete Genomics Inc. 4 pairs of ESCC and blood 4 pairs of gastric non-cardia cancer and blood 7 pairs of gastric cardia cancer and blood

Circos Plot Of WGS data from A Gastric Cardia Cancer: Somatic SVs, CNAs, And SNVs

Somatic Structural Variations (SVs) In ESCC And Gastric Cancer

MACROD2 Exon 6 Was Frequently Deleted in Gastric Cancer O-acetyl-ADP-ribose deacetylase MACROD2 isoform 1

Mutation Substitution Patterns

Collaborators CCRHoward YangHuaitian Liu Mitsutaka Kadota Lalage WakefieldKent HunterBeverly MockDinah Singer Kevin GardnerJing HuangXin WangLi Yang Thomas RiedStephen HewittPaul MeltzerSean Davis DCEGPhil TaylorNan HuAlisa GoldsteinChristian Abnet Neal FreedmanSandy DawseyGretchen GierachNeil Caporaso Jonine Figueroa CBIITDaoud Meerzaman DCPMark ShermanBarbara DunnRonald LubetAsad Umar DCTDJay JiJason Lih UMASSKathleen Arcaro UNCMelissa Troester Purdue UniversitySulma Mohammed Windber Research InstituteHai Hu Toyama UniversityJunya Fukuoka

Dr. Robert Wiltrout Dr. Glenn Merlino